Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2516 | 0.94 | IDO1 (0.48) | IDO1LMNASMN1; SMN2FFAR1HDAC3 | |
| SCHEMBL99521 | 0.93 | MEN1 (0.49) | IDO1LMNASMN1; SMN2FFAR1NPC1 | |
| SCHEMBL5544955 | 0.93 | MEN1 (0.49) | IDO1LMNASMN1; SMN2FFAR1NPC1 | |
| SCHEMBL11108660 | 0.92 | MAPT (0.48) | IDO1LMNAFFAR1SIGMAR1MAOA | |
| SCHEMBL97331 | 0.92 | MAPT (0.48) | IDO1LMNAFFAR1SIGMAR1MAOA | |
| SCHEMBL96961 | 0.92 | MAPT (0.48) | IDO1LMNAFFAR1SIGMAR1MAOA | |
| SCHEMBL11103088 | 0.92 | MAPT (0.48) | IDO1LMNAFFAR1SIGMAR1MAOA | |
| SCHEMBL11103301 | 0.92 | MAPT (0.48) | IDO1LMNAFFAR1SIGMAR1MAOA | |
| SCHEMBL11102439 | 0.92 | MAPT (0.48) | IDO1LMNAFFAR1SIGMAR1MAOA | |
| SCHEMBL5542416 | 0.91 | MEN1 (0.47) | IDO1LMNASMN1; SMN2FFAR1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104363756-A | Agricultural plant-protecting agent containing dipeptide derivative as active ingredient | RURAL DEV ADMIN | 2015-02-18 | — | — | CN | claimed |
| US-20090318502-A1 | Pharmaceutical Compositions Comprising a Hypoglycemic Agent and Methods of Using Same | INTRANASAL THERAPEUTICS, INC. (US) | 2009-12-24 | — | — | US | claimed |
| CN-101480501-A | Substitute material for repairing articular cartilage and preparation method | UNIV SICHUAN (CN) | 2009-07-15 | — | — | CN | claimed |
| WO-2007111933-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING A HYPOGLYCEMIC AGENT AND METHODS OF USING SAME | INTRANASAL THERAPEUTICS , INC. (US) | 2007-10-04 | — | — | WO | claimed |
| EP-1322608-B1 | DELTA1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-6995185-B2 | Δ1-pyrrolines used as pesticides | BAYER CROPSCIENCE AG (DE) | 2006-02-07 | — | — | US | claimed |
| CN-1227228-C | Delta as pesticide1-pyrrolines | BAYER CROPSCIENCE AG (DE) | 2005-11-16 | — | — | CN | claimed |
| EP-1494700-A2 | CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS | Cytovia, Inc. (US) | 2005-01-12 | — | — | EP | claimed |
| US-20040068122-A1 | Delta1-pyrrolines used as pesticides | BAYER CROPSCIENCE AG (DE) | 2004-04-08 | — | — | US | claimed |
| CN-1476430-A | Delta as pesticide1-pyrrolines | �ݶ�ũ�����ѧ�ɷݹ�˾ | 2004-02-18 | — | — | CN | claimed |
| WO-2004002401-A2 | CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS | CYTOVIA, INC. (US) | 2004-01-08 | — | — | WO | claimed |
| EP-1322608-A1 | DELTA1-PYRROLINES USED AS PESTICIDES | Bayer CropScience AG (DE) | 2003-07-02 | — | — | EP | claimed |
| EP-1177168-A4 | CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA INC (US) | 2003-06-25 | — | — | EP | claimed |
| JP-2002541237-A | — | — | 2002-12-03 | — | — | JP | claimed |
| WO-2002024646-A1 | DELTA1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2002-03-28 | — | — | WO | claimed |
| EP-1177168-A1 | CASPASE INHIBITORS AND THE USE THEREOF | Cytovia, Inc. (US) | 2002-02-06 | — | — | EP | claimed |
| WO-2000061542-A1 | CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2000-10-19 | — | — | WO | claimed |
| WO-2024075815-A1 | 8-HYDROXYQUINOLINE COMPOUND AND USE THEREOF | 国立大学法人大阪大学 | 2024-04-11 | — | — | WO | disclosed |
| US-4199570-A | AZETIDINE, PYRROLIDINE, OR PIPERIDINE | SHIONOGI & CO., LTD. (JP) | 1980-04-22 | — | — | US | disclosed |
| EP-0001280-A2 | 1-N-acylated-4-O-glycosyl-6-O-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them | SHIONOGI & CO., LTD. (JP) | 1979-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040068122-A1 | Delta1-pyrrolines used as pesticides | DDT, ADRA1D, OPRD1 | IDO1 342/4885LMNA 3251/4885SMN1; SMN2 1679/4885 |
| US-20090318502-A1 | Pharmaceutical Compositions Comprising a Hypoglycemic Agent and Methods of Using Same | IAPP, GPR119, SLC5A2 | IDO1 3450/4885LMNA 3274/4885SMN1; SMN2 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.